HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/3/G607    most recent 00055.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Zuckerbraun, B. S. Articles by Ford, H. R. Search for Related Content PubMed PubMed Citation Articles by Zuckerbraun, B. S. Articles by Ford, H. R.

INFLAMMATION/IMMUNITY/MEDIATORS

Carbon monoxide protects against the development of experimental necrotizing enterocolitis

¹Department of Surgery and ²Department of Pathology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; ³Department of Surgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston Massachusetts; and ⁴Division of Pediatric Surgery, Children's Hospital of Los Angeles, Los Angeles, California

Submitted 8 February 2005 ; accepted in final form 30 April 2005

Necrotizing enterocolitis (NEC) is a disease of neonates that is increasing in incidence and often results in significant morbidity and mortality. Carbon monoxide (CO), a byproduct of the catabolism of heme, is known to have anti-inflammatory and antiapoptotic properties. In this study, we aimed to demonstrate that inhaled CO protects against the development of intestinal inflammation in a model of experimental NEC as well as decreases enterocyte cell death in vitro. Additionally, we also aimed to demonstrate that CO decreases enterocyte production of inducible nitric oxide synthase (iNOS) and nitric oxide (NO). Neonatal rats were exposed to intermittent hypoxia exposure and formula feeding to induce experimental NEC. Animals randomized to CO treatment were put in an environment containing 0.025% CO for 1 h/day on days 1–3 of life. All animals were killed on day 4 of life. In vitro experiments were performed with IEC-6 cells, a rat enterocyte cell line. Cells were examined for viability, iNOS production, and elaboration of NO. We found that CO diminished levels of serum inflammatory cytokines and nitrites, protected against intestinal inflammation, and decreased ileal iNOS production and protein nitration in a model of experimental NEC. In vitro, CO decreased cytokine- or hypoxia/endotoxin-induced iNOS and NO production. CO also abrogated TNF-- and actinomycin D-induced apoptosis or hypoxia/endotoxin-induced cell death. In conclusion, 1 h of daily low-dose inhaled CO protected against the development of intestinal inflammation in a model of experimental NEC. iNOS and NO production were decreased by CO both in vivo and in vitro. CO may prove to be a useful clinical adjunct in the treatment of NEC.

heme oxygenase; nitric oxide

This article has been cited by other articles:

				J. M. Rhoads, Y. Liu, X. Niu, S. Surendran, and G. Wu Arginine Stimulates cdx2-Transformed Intestinal Epithelial Cell Migration via a Mechanism Requiring Both Nitric Oxide and Phosphorylation of p70 S6 Kinase J. Nutr., September 1, 2008; 138(9): 1652 - 1657. [Abstract] [Full Text] [PDF]

				K. A. Kirkby and C. A. Adin Products of heme oxygenase and their potential therapeutic applications Am J Physiol Renal Physiol, March 1, 2006; 290(3): F563 - F571. [Abstract] [Full Text] [PDF]

				L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]

				R. Zamora, Y. Vodovotz, B. Betten, C. Wong, B. Zuckerbraun, K. F. Gibson, and H. R. Ford Intestinal and hepatic expression of BNIP3 in necrotizing enterocolitis: regulation by nitric oxide and peroxynitrite Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G822 - G830. [Abstract] [Full Text] [PDF]